NCT04537715 2025-02-19Effects of Itraconazole and Rifampin on the Blood Tazemetostat LevelsIpsenPhase 1 Completed42 enrolled 39 charts
NCT05415098 2022-11-16Study of Safety, Pharmacokinetic and Efficacy of APG-5918 in Advanced Solid Tumors or LymphomasAscentage Pharma Group Inc.Phase 1 Unknown90 enrolled
NCT01655225 2022-04-08A Study of LY3023414 in Participants With Advanced CancerEli Lilly and CompanyPhase 1 Completed156 enrolled
NCT03538028 2020-10-30A Safety and Tolerability Study of INCAGN02385 in Select Advanced MalignanciesIncyte CorporationPhase 1 Completed22 enrolled
NCT02812875 2020-06-26A Study of CA-170 (Oral PD-L1, PD-L2 and VISTA Checkpoint Antagonist) in Patients With Advanced Tumors and LymphomasCuris, Inc.Phase 1 Completed71 enrolled
NCT03638206 2019-12-11Autologous CAR-T/TCR-T Cell Immunotherapy for MalignanciesShenzhen BinDeBio Ltd.Phase 1/2 Unknown73 enrolled
NCT02599194 2019-01-0318F-FSPG PET/CT for Cancer Patients on TherapyStanford UniversityPhase 2 Completed7 enrolled 6 charts
NCT00154388 2016-11-18Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare DiseasesNovartisPhase 2 Completed185 enrolled
NCT00413075 2015-07-08Study of Oral PXD101 in Patients With Advanced Solid Tumors or LymphomaValerio TherapeuticsPhase 1 Completed121 enrolled
NCT00375245 2014-01-17Rapamycin With Grapefruit Juice for Advanced MalignanciesUniversity of ChicagoPhase 1 Completed41 enrolled